|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0002199,
umls-concept:C0018270,
umls-concept:C0030705,
umls-concept:C0035525,
umls-concept:C0078058,
umls-concept:C0087111,
umls-concept:C0229671,
umls-concept:C0380603,
umls-concept:C0441889,
umls-concept:C0524910,
umls-concept:C1171892,
umls-concept:C1280500,
umls-concept:C1510411
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2006-3-7
|
|
pubmed:abstractText |
To assess the role of transforming growth factor-beta1 (TGF-beta1), vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in the pathogenesis of fibrosis associated with chronic hepatitis C (CHC) and to evaluate the influence of the antiviral therapy on above parameter levels depending on the treatment results (complete response or no response).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1007-9327
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
14
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
961-5
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16521228-Adult,
pubmed-meshheading:16521228-Antiviral Agents,
pubmed-meshheading:16521228-Biological Markers,
pubmed-meshheading:16521228-Female,
pubmed-meshheading:16521228-Fibroblast Growth Factor 2,
pubmed-meshheading:16521228-Hepatitis C, Chronic,
pubmed-meshheading:16521228-Humans,
pubmed-meshheading:16521228-Interferon-alpha,
pubmed-meshheading:16521228-Male,
pubmed-meshheading:16521228-Middle Aged,
pubmed-meshheading:16521228-Prognosis,
pubmed-meshheading:16521228-Ribavirin,
pubmed-meshheading:16521228-Transforming Growth Factor beta,
pubmed-meshheading:16521228-Transforming Growth Factor beta1,
pubmed-meshheading:16521228-Vascular Endothelial Growth Factor A
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Effect of interferon alpha and ribavirin treatment on serum levels of transforming growth factor-beta1, vascular endothelial growth factor, and basic fibroblast growth factor in patients with chronic hepatitis C.
|
|
pubmed:affiliation |
Department of Infectious Diseases, Medical University of Silesia, Zjednoczenia 10, 41-500 Chorzow, Poland. e.janczewska@neostrada.pl
|
|
pubmed:publicationType |
Journal Article
|
